JACQUELINE FOX: Open Payments
NPI 1447875430 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 28 payments from 10 companies in 2025. Trend: 2023 $1,341 · 2024 $1,782 · 2025 $726
Food & beverage: $726
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $227 |
| Novo Nordisk Inc | 1 | $110 |
| Otsuka America Pharmaceutical, Inc. | 4 | $102 |
| Lilly USA, LLC | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $54 |
| SANOFI PASTEUR INC. | 2 | $49 |
| Neurocrine BioSciences, Inc. | 2 | $34 |
| PFIZER INC. | 1 | $30 |
| CeQur Corporation | 1 | $23 |
| ABBVIE INC. | 1 | $15 |
Products named: Ozempic, REXULTI, JARDIANCE, AIRSUPRA, FARXIGA, BREZTRI, MOUNJARO, INGREZZA.
Industry payments across MA — which companies pay providers there.
